机译:GW29-E2015终点终点结果的前瞻性,单盲,多中心,随机,控制,临床试验,与冠心病患者的蒂沃利相比,西罗莫士洗脱支架的疗效和安全性(Mistent?系统)的疗效和安全性 疾病
The General Hospital of Shenyang Military;
Inner Mongolia People’s Hospital;
The First Affiliated Hospital of Baotou University;
West China of Medicine Hospital Sichuang University;
National Center for Cardiovascular Fuwaui Hospital CAMS&
PUMC;
National Center for Cardiovascular Fuwaui Hospital CAMS&
PUMC;
The First Hospital of Jilin University;
The First Hospital of Lanzhou University;
The Second Xiangya Hospital of Central South University;
TEDA International Cardiovascular Hospital;
TEDA International Cardiovascular Hospital;
The Second Hospital of Shanxi Medical University;
The Second Affiliated Hospital of Nanchang University;
Shanghai Ninth People’s Hospital;
The First Affiliated Hospital of Inner Mongolia Medical University;
Sir Run Run Shaw Hospital of Medicine Zhejiang University;
The Third Xiangya Hospital of Central South University;
The First Affiliated Hospital of Xi’an Jiaotong University;
The General Hospital of Shenyang Military;
The General Hospital of Shenyang Military;
机译:GW29-E2015终点终点结果的前瞻性,单盲,多中心,随机,控制,临床试验,与冠心病患者的蒂沃利相比,西罗莫士洗脱支架的疗效和安全性(Mistent?系统)的疗效和安全性 疾病
机译:用新型铂铬薄支架治疗De Novo冠状动脉后的临床和血管造影结果:Perseus的主要结果(随机试验中的前瞻性评估,随机试验使用紫杉孢子紫杉醇洗脱冠状动脉支架 系统)试验。
机译:新型铂铬薄支撑支架治疗从头冠状动脉狭窄后的临床和血管造影结果:PERSEUS的主要结果(使用TAXUS元素紫杉醇洗脱冠状动脉支架的安全性和有效性的随机试验的前瞻性评估系统)试用。
机译:生物可吸收聚合物雷帕霉素洗脱支架(Excel支架)对冠心病患者的临床疗效和安全性
机译:快速通道:生物可吸收性聚合物西罗莫司洗脱冠状动脉支架系统的随机前瞻性洲际评估:CENTURY II(新的Terumo药物洗脱冠状动脉支架系统在冠状动脉疾病患者治疗中的临床评估)试验
机译:新型铂铬细支气管支架支架治疗De Novo冠状动脉狭窄后的临床和血管造影结果(初步评估使用TAXUS元素紫杉醇洗脱冠状动脉支架系统的安全性和有效性的随机试验) )试用